Cameco gains as uranium market sentiment improves amid higher term-price signals and supply-tightness backdrop

Cameco Corporation (CCJ) is up 4.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a broader uranium-equities bid as indicators for long-term contracting strengthened, reinforcing the narrative of tight supply and improving utility demand. Cameco’s recent full-year update and constructive outlook likely added support as investors rotated back into large-cap uranium exposure.

Details:

TradeTech’s monthly Long-Term Uranium Price Indicator was marked higher to US$93.00/lb as of March 31, 2026, reflecting reported long-term market transactions and firmer contracting activity during Q1.

Cameco’s latest annual results commentary highlighted a constructive demand environment and reiterated that 2026 guidance for its Westinghouse investment remained strong, supporting the view that earnings drivers extend beyond uranium spot pricing.

Cameco also disclosed receiving an April cash dividend from JV Inkai (net of withholdings), a reminder of near-term cash-flow contributions from its Kazakhstan exposure.

Separate industry updates have pointed to potential reductions or tighter guidance around 2026 supply from Kazakhstan’s uranium sector, which can lift sentiment for incumbent producers with available, reliable capacity.

Sources:

Cameco (Investor Relations), National Law Review, World Nuclear News

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CCJ Hedge Fund Activity

We have seen 478 institutional investors add shares of $CCJ stock to their portfolio, and 405 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 2,212,569 shares (-12.8%) from their portfolio in Q4 2025, for an estimated $202,427,937
FIL LTD removed 2,094,018 shares (-19.4%) from their portfolio in Q4 2025, for an estimated $191,581,706
CITIGROUP INC removed 1,781,746 shares (-71.4%) from their portfolio in Q4 2025, for an estimated $163,011,941
MARSHALL WACE, LLP added 1,729,454 shares (+7481.3%) to their portfolio in Q4 2025, for an estimated $158,227,746
ALLIANCEBERNSTEIN L.P. removed 1,638,428 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $149,899,777
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 1,556,157 shares (+12.0%) to their portfolio in Q4 2025, for an estimated $142,372,803
MIZUHO MARKETS CAYMAN LP removed 1,530,760 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $140,049,232

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CCJ Congressional Stock Trading

Members of Congress have traded $CCJ stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CCJ stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/17 and 2 sales worth up to $30,000 on 01/09, 12/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CCJ Analyst Ratings

Wall Street analysts have issued reports on $CCJ in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

GLJ Research issued a "Buy" rating on 02/18/2026
RBC Capital issued a "Outperform" rating on 11/13/2025
Goldman Sachs issued a "Buy" rating on 10/29/2025

To track analyst ratings and price targets for $CCJ, check out Quiver Quantitative's $CCJ forecast page.

$CCJ Price Targets

Multiple analysts have issued price targets for $CCJ recently. We have seen 4 analysts offer price targets for $CCJ in the last 6 months, with a median target of $150.0.

Here are some recent targets:

Gordon L. Johnson from GLJ Research set a target price of $171.2 on 02/18/2026
Andrew D. Wong from RBC Capital set a target price of $160.0 on 02/17/2026
George Eadie from UBS set a target price of $140.0 on 11/10/2025
Brian Lee from Goldman Sachs set a target price of $109.0 on 10/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.